Pathological gambling in two patients on dopamine replacement therapy for Parkinson’s disease

ISSN： 1590-1874

Source： Neurological Sciences, Vol.25, Iss.2, 2004-06, pp. : 98-101

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Dopamine receptor agonists in the therapy of Parkinson’s disease

By Foley P. Gerlach M. Double K. L. Riederer P.

Journal of Neural Transmission, Vol. 111, Iss. 10-11, 2004-10 ,pp. : 1375-1446

Springer Publishing Company

Access to resources Recommend Favorite

Therapy for dyskinesias in Parkinson’s disease patients

By Stefani Alessandro Pierantozzi Mariangela Koch Giacomo Galati Salvatore Stanzione Paolo

Future Neurology, Vol. 5, Iss. 2, 2010-03 ,pp. : 277-299

Future Medicine

Access to resources Recommend Favorite

Pathological proteins in Parkinson’s disease: Focus on the proteasome

By Snyder Heather Wolozin Benjamin

Journal of Molecular Neuroscience, Vol. 24, Iss. 3, 2004-10 ,pp. : 425-442

Humana Press, Inc

Access to resources Recommend Favorite

Clarifying the pathological progression of Parkinson’s disease

By Halliday Glenda

Acta Neuropathologica, Vol. 115, Iss. 4, 2008-04 ,pp. : 377-378

Springer Publishing Company

Access to resources Recommend Favorite

Apathy in patients with Parkinson’s disease

By Shulman Lisa M.

International Review of Psychiatry, Vol. 12, Iss. 4, 2000-11 ,pp. : 298-306

Informa Healthcare

Access to resources Recommend Favorite